BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1980276)

  • 1. Liquid chromatographic studies on the aqueous solution conformation of substituted benzamides related to remoxipride.
    Clark CR; Smith FT; Clark MR; Garcia-Roura LE
    J Chromatogr Sci; 1990 Mar; 28(3):93-6. PubMed ID: 1980276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatographic studies on the aqueous solution conformation of substituted benzamide drug models.
    Clark CR; Garcia-Roura LE
    J Chromatogr Sci; 1989 Mar; 27(3):111-7. PubMed ID: 2708496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 5-substituted 5-hydroxy-2-pyrrolidones, metabolites of the antipsychotic benzamide remoxipride.
    Gawell L; Hagberg CE; Högberg T; Widman M
    Acta Chem Scand (Cph); 1989 May; 43(5):476-80. PubMed ID: 2577294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatic and amine substituent effects on the apparent lipophilicities of N-[(2-pyrrolidinyl)methyl]-substituted benzamides.
    Schmidt DE; Votaw JR; Kessler RM; de Paulis T
    J Pharm Sci; 1994 Mar; 83(3):305-15. PubMed ID: 8207673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid state conformations and antidopaminergic effects of remoxipride hydrochloride and a closely related salicylamide, FLA 797, in relation to dopamine receptor models.
    Högberg T; Rämsby S; de Paulis T; Stensland B; Csöregh I; Wägner A
    Mol Pharmacol; 1986 Oct; 30(4):345-51. PubMed ID: 2945089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformationally restricted analogues of remoxipride as potential antipsychotic agents.
    Norman MH; Kelley JL; Hollingsworth EB
    J Med Chem; 1993 Oct; 36(22):3417-23. PubMed ID: 7901417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of remoxipride in plasma and urine by reversed-phase column liquid chromatography.
    Nilsson LB
    J Chromatogr; 1990 Mar; 526(1):139-50. PubMed ID: 1971278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-line low-level radiometric detection of [14C]remoxipride in liquid chromatographic effluents. Application to urine samples.
    Veltkamp AC; Das HA; Frei RW; Brinkman UA
    J Chromatogr; 1987 Jan; 384():357-69. PubMed ID: 2880858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(o-tolyl)-2-bromo-4,5-dimethoxybenzamide.
    Rivera-Gandia J; Morales N; Cox O; Huang SD
    Acta Crystallogr C; 1998 Jan; 54 ( Pt 1)():69-71. PubMed ID: 9485570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man.
    Widerlöv E; Termander B; Nilsson MI
    Eur J Clin Pharmacol; 1989; 37(4):359-63. PubMed ID: 2574673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of near-infrared spectroscopy for differential detection of neuroleptics, derivatives of benzamides].
    Kalekin RA; Salomatin EM; Kalekina VA; Volkova AA; Dadabaev VK
    Sud Med Ekspert; 2010; 53(3):33-5. PubMed ID: 20734788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remoxipride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in schizophrenia.
    Wadworth AN; Heel RC
    Drugs; 1990 Dec; 40(6):863-79. PubMed ID: 1981869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the properties of stationary phases for liquid chromatography in aqueous mobile phases using aromatic sulphonic acids as the test compounds.
    Jandera P; Bocian S; Molíková M; Buszewski B
    J Chromatogr A; 2009 Jan; 1216(2):237-48. PubMed ID: 19081105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
    Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L
    Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further consideration of the gas-liquid chromatographic method for determining the intramolecular hydrogen bond energies with the example of 2-substituted phenols.
    Skvortsov IM; Makarov OE; Fedorov EE
    J Chromatogr A; 2006 Nov; 1132(1-2):248-55. PubMed ID: 16919650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remoxipride: pharmacokinetics and effect on plasma prolactin.
    Movin-Osswald G; Hammarlund-Udenaes M
    Br J Clin Pharmacol; 1991 Sep; 32(3):355-60. PubMed ID: 1685665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic determination of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4- methylaminobenzamide in rat blood and brain using electrochemical detection.
    Imamura Y; Shibanoki S; Kubo T; Kogure M; Ishii Y; Gotoh Y; Asai S; Ishikawa K
    J Chromatogr; 1990 Mar; 526(1):282-8. PubMed ID: 1971279
    [No Abstract]   [Full Text] [Related]  

  • 18. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of predictive retention-activity relationship models of antipsychotic drugs by micellar liquid chromatography.
    Martín-Biosca Y; Molero-Monfort M; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    Biomed Chromatogr; 1999 Nov; 13(7):478-92. PubMed ID: 10534760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of subcritical water as an eluent for reversed-phase liquid chromatography--disruption of the hydrogen-bond network at elevated temperature and its consequences.
    Allmon SD; Dorsey JG
    J Chromatogr A; 2010 Sep; 1217(37):5769-75. PubMed ID: 20692667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.